Sonic Fund II, L.P. 13D and 13G filings for Fennec Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 10:39 am Purchase | 2025-12-31 | 13G | FENNEC PHARMACEUTICALS, INC. O FENC | Sonic Fund II, L.P. | 2,799,959 8.200% | 330,079 (+13.36%) | Filing |
| 2022-02-14 09:08 am Sale | 2021-12-31 | 13G | FENNEC PHARMACEUTICALS, INC. O FENC | Sonic Fund II, L.P. | 2,469,880 9.500% | -25,873 (-1.04%) | Filing |